and hybridization with labeled probes [Southern (5) and northern (6) blots], and arguably the most powerful of all: polymerase chain reaction (PCR) (7-9). Since its invention more than a decade ago, laboratorians have recognized the potential usefulness of PCR but also the need to develop standards of practice for its implementation as a clinical diagnostic tool.
The components of PCR are conceptually simple: target DNA to be amplified, oligonucleotide primers, temperature-stable DNA polymerase, nucleotides, and appropriate buffer and salt solutions.
The power of PCR is its theoretical twofold amplification during each cycle, a cycle being defined by temperature shifts in which DNA is serially denatured, annealed to primers, and enzymatically extended. Despite these operational simplicities, practitioners of PCR generally must contend with unique problems of optimizing individual assays, including keeping the assay in an exponential phase of doubling to maintain linear response.
The most probable clinical uses of PCR will be for diagnosis of infectious diseases, genetic diseases, identity testing, and cancer. 
